Ironwood Pharmaceuticals | IRWD - Loan Capital


Ironwood Pharmaceuticals reported $583.99M in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Almirall EUR 303.77M 21.04M Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
Ardelyx USD 203.52M 683K Mar/2026
Astellas Pharma JPY 320B 0 Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Halozyme Therapeutics USD 1.94B 1.79M Jun/2026
Incyte USD 28.42M 994K Jun/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
MacroGenics USD 68.71M 1.29M Mar/2026
Moderna USD 597M 6M Jun/2026
Myriad Genetics USD 120.7M 400K Jun/2026
Pacira USD 363.12M 4.53M Jun/2026
PTC Therapeutics USD 535.52M 248.58M Jun/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
Takeda JPY 4.42T 50.32B Jun/2026
Ultragenyx Pharmaceutical USD 1.13B 19M Mar/2026
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024